Hemavant is a clinical-stage biopharmaceutical company dedicated to developing innovative targeted therapeutics to improve the lives of patients with blood disorders and hematological malignancies.
Company Details
- Employees
- 2
- Founded
- -
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- Greater Boston.
Hemavant Sciences Questions
Hemavant Sciences's LinkedIn profile is https://www.linkedin.com/company/hemavant-sciences
Hemavant Sciences has
2 employees.
View email and phone details for 2
employees at Hemavant Sciences.
Hemavant Sciences's industry is
Pharmaceutical Manufacturing
Hemavant Sciences's top competitors are
Sumitomo Pharma America, Inc.,
Pulmovant,
Myovant Sciences,
Roivant,
Priovant Therapeutics,
Freethink Technologies, Inc.,
Catalyst Ppm,
Immunovant,
Kinevant Sciences,
Aruvant.
Hemavant Sciences's categories are Pharmaceutical Manufacturing
Hemavant Sciences's founding year is 2022
